European Commission clears Pfizer acquisition of Pharmacia with proviso

The Financial Times of the U.K. reported that Pfizer Inc's acquisition of Pharmacia Corp. for $54 billion in stock was approved by the European Commission on February 27 under the conditions that some launched items and compounds in development by the two companies should be divested prior to EC's final approval, in fear that their combined portfolio may trigger any exclusive sales in the ethic...